Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 12544881)

Published in Transplantation on January 15, 2003

Authors

Abhay Vats1, Ron Shapiro, Parmjeet Singh Randhawa, Velma Scantlebury, Acar Tuzuner, Malika Saxena, Michael L Moritz, T James Beattie, Thomas Gonwa, Michael D Green, Demetrius Ellis

Author Affiliations

1: Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA. Abhay.vats@chp.edu

Articles citing this

Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03

Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev (2003) 1.91

Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA. J Clin Microbiol (2003) 1.72

Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol (2008) 1.60

Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46

Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant (2007) 1.41

Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol (2005) 1.26

Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother (2006) 1.18

BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol (2008) 1.13

Development of a loop-mediated isothermal amplification assay for rapid detection of BK virus. J Clin Microbiol (2007) 1.11

BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol (2007) 1.05

Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol (2008) 0.93

Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients. Indian J Urol (2009) 0.92

Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant (2008) 0.91

Monitoring and managing viral infections in pediatric renal transplant recipients. Pediatr Nephrol (2011) 0.86

Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains. Antimicrob Agents Chemother (2007) 0.84

BK Virus-Associated Nephropathy in Kidney Transplant Recipients. Ochsner J (2010) 0.83

The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment. Pediatr Nephrol (2010) 0.81

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression. J Transplant (2011) 0.81

High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype. J Clin Microbiol (2009) 0.81

Association of neurotropic viruses in HIV-infected individuals who died of secondary complications of tuberculosis, cryptococcosis, or toxoplasmosis in South India. J Clin Microbiol (2013) 0.80

BK polyoma virus infection and renal disease in non-renal solid organ transplantation. Clin Kidney J (2015) 0.80

Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus. Virol J (2010) 0.79

Anti-BK virus activity of nucleoside analogs. Antimicrob Agents Chemother (2008) 0.79

Molecular characterization of BK and JC viruses circulating among potential kidney donors in Kuwait. Biomed Res Int (2013) 0.77

Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. Transpl Infect Dis (2012) 0.76

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant (2009) 0.76

Viruses and kidney disease: beyond HIV. Semin Nephrol (2008) 0.76

BK virus-hemorrhagic cystitis following allogeneic stem cell transplantation: Clinical characteristics and utility of leflunomide treatment. Turk J Haematol (2016) 0.75

Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis? J Transplant (2010) 0.75

Articles by these authors

Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med (2010) 6.26

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2003) 4.50

Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Maintenance Intravenous Fluids in Acutely Ill Patients. N Engl J Med (2015) 4.00

A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med (2008) 3.97

Counterfeit anti-infective drugs. Lancet Infect Dis (2006) 3.91

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72

Murder by fake drugs. BMJ (2002) 2.54

Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor-quality and underdosed intramuscular artemether. Am J Trop Med Hyg (2008) 2.48

Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med (2009) 2.36

Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell (2012) 2.33

Impact of poor-quality medicines in the 'developing' world. Trends Pharmacol Sci (2010) 2.19

Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. Am J Trop Med Hyg (2006) 1.79

Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry. ChemMedChem (2006) 1.79

Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J (2011) 1.76

Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr (2003) 1.71

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68

Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant (2003) 1.64

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58

Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation (2009) 1.54

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52

Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation (2008) 1.52

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Laparoscopic fundoplication with prosthetic hiatal closure. World J Surg (2007) 1.49

Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46

Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation. Anal Chem (2007) 1.45

Water water everywhere: standardizing postoperative fluid therapy with 0.9% normal saline. Anesth Analg (2010) 1.44

Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42

Proposed live donor nephrectomy complication classification scheme. Transplantation (2006) 1.41

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J (2009) 1.35

Promotion of altruistic donation. Transplantation (2009) 1.33

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation (2005) 1.32

Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. Analyst (2010) 1.31

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30

Immunosuppression: practice and trends. Am J Transplant (2004) 1.28

The pathobiology of polyomavirus infection in man. Adv Exp Med Biol (2006) 1.27

Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis (2007) 1.27

Bone disease as a new complication of hyponatremia: moving beyond brain injury. Clin J Am Soc Nephrol (2010) 1.25

Oxidative stress in malaria. Int J Mol Sci (2012) 1.24

Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation (2002) 1.23

Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med (2011) 1.19

Phylogenetic analysis of polyomavirus BK sequences. J Virol (2006) 1.19

Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother (2006) 1.18

Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes (2009) 1.18

Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One (2013) 1.16

A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation (2005) 1.14

Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2012) 1.14

Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatr Nephrol (2006) 1.12

Quantitation of DNA of polyomaviruses BK and JC in human kidneys. J Infect Dis (2005) 1.12

An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. Am J Trop Med Hyg (2010) 1.12

Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12

Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol (2006) 1.12

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11

Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation (2008) 1.08

Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis (2002) 1.07

Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol (2005) 1.06

Is chronic hyponatremia a novel risk factor for hip fracture in the elderly? Nephrol Dial Transplant (2012) 1.06

Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol (2005) 1.05

Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis. Am J Kidney Dis (2011) 1.03

Early urethral (Foley) catheter removal positively affects length of stay after renal transplantation. Transplantation (2007) 1.03

Desorption electrospray ionization reactions between host crown ethers and the influenza neuraminidase inhibitor oseltamivir for the rapid screening of Tamiflu. Analyst (2008) 1.02

Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation (2010) 1.02

Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation (2012) 1.01

Undertreatment of elderly patients with non-small-cell lung cancer. Clin Lung Cancer (2005) 1.01

A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol (2005) 0.99

DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation (2002) 0.99

Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol (2002) 0.98

Preview of Hawaii Cancer Facts and Figures 2010. Hawaii Med J (2010) 0.98

Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant (2004) 0.98

Anticancer agents and cardiotoxicity. Semin Oncol (2006) 0.97

Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation (2004) 0.97

Hyponatremia in marathon runners. N Engl J Med (2005) 0.97

Renal cell carcinoma from a transplanted allograft: two case reports and a review of the literature. Clin Genitourin Cancer (2008) 0.96

Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int (2003) 0.95

Urinary excretion of calcium and phosphate in preterm infants. Pediatr Nephrol (2004) 0.95

Correlation of histologic findings on preimplant biopsy with kidney graft survival. Transpl Int (2008) 0.95

Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol (2008) 0.95

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon. Malar Res Treat (2012) 0.95

Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Hum Immunol (2006) 0.95

Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clin Breast Cancer (2003) 0.95

Detecting counterfeit antimalarial tablets by near-infrared spectroscopy. J Pharm Biomed Anal (2008) 0.94

Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94

A locus for renal malformations including vesico-ureteric reflux on chromosome 13q33-34. J Am Soc Nephrol (2006) 0.94

Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donors. J Am Geriatr Soc (2007) 0.92

Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am J Hypertens (2004) 0.92

Direct quantitation of active ingredients in solid artesunate antimalarials by noncovalent complex forming reactive desorption electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2007) 0.91

Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol (2006) 0.91

Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91